Related Experiment Video
Updated: Aug 16, 2026
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
New genetic tactics to model alveolar rhabdomyosarcoma in the mouse
Charles Keller1, Mario R Capecchi
1Department of Cellular and Structural Biology, Children's Cancer Research Institute, The University of Texas Health Science Center, San Antonio, Texas, USA.
Abstract:
Using conditional knock-in and knock-out techniques, we designed a mouse model of the childhood muscle cancer alveolar rhabdomyosarcoma (ARMS) that is driven by the chromosomal translocation product, Pax3:Fkhr. Tumors that closely recapitulate the spectrum of molecular markers and histology seen in human ARMS are exclusively produced in this model. Unexpectedly, expression of Pax3:Fkhr in muscle satellite cells did not produce tumors, but it did in differentiating myofibers. Expression of Pax3:Fkhr in muscle is necessary but not sufficient to initiate tumorigenesis at high frequency. This model offers new insight into the roots of alveolar rhabdomyosarcoma and illustrates the utility of Cre-loxP technology for studying otherwise inaccessible cancers in the mouse.
Insights
Researchers created a mouse model for alveolar rhabdomyosarcoma (ARMS), a childhood muscle cancer. This model, using Pax3:Fkhr, reveals that differentiating muscle cells, not satellite cells, are key to tumor development.
Area of Science:
- Developmental Biology
- Cancer Research
- Genetics and Genomics
Background:
- Alveolar rhabdomyosarcoma (ARMS) is a significant childhood muscle cancer.
- The Pax3:Fkhr fusion protein, resulting from a chromosomal translocation, is a known driver of ARMS.
- Understanding the cellular origins and specific requirements for ARMS initiation is crucial for developing targeted therapies.
Purpose of the Study:
- To develop a conditional mouse model accurately recapitulating human ARMS.
- To investigate the role of Pax3:Fkhr expression in different muscle cell types during tumorigenesis.
- To gain insights into the cellular and molecular mechanisms underlying ARMS development.
Main Methods:
- Conditional knock-in and knock-out strategies utilizing Cre-loxP technology were employed.
- The Pax3:Fkhr fusion gene was conditionally expressed in specific muscle cell populations.
- Histological and molecular analyses were performed to characterize tumor development and cellular origins.
Main Results:
- The generated mouse model exclusively produced tumors that closely mimicked human ARMS in histology and molecular profiles.
- Expression of Pax3:Fkhr in differentiating myofibers, but not in muscle satellite cells, led to tumor formation.
- Pax3:Fkhr expression was found to be necessary but not sufficient for high-frequency tumor initiation.
Conclusions:
- This novel mouse model provides a powerful tool for studying ARMS pathogenesis.
- Differentiating myofibers are identified as the critical cell type for ARMS initiation driven by Pax3:Fkhr.
- The study highlights the utility of advanced genetic engineering techniques, like Cre-loxP, for modeling complex cancers.
